Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
ICCC
#3451
Immucell Corp
6.4
0
+0.79%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.79%
Aylık değişim
+0.63%
6 aylık değişim
+4.40%
Yıllık değişim
+21.67%
Önceki kapanış
6.3
5
Open
6.4
0
Bid
Ask
Low
6.4
0
High
6.4
0
Hacim
3
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
ICCC
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
7.22 M
7.74 M
7.75 M
7.75 M
8.98 M
—
Valuation ratios
Enterprise value
36.01 M
51.76 M
44.41 M
60.1 M
46.01 M
204.41 M
Price to earnings ratio
42.5
-800.01
-20.25
-6.67
-19.81
-86.37
Price to sales ratio
2.8
3.16
2.7
2.22
1.59
7.13
Price to cash flow ratio
32.62
63.66
-32.51
-8.29
117.52
199.16
Price to book ratio
1.52
1.86
1.65
1.55
1.53
2.9
Enterprise value to EBITDA ratio
37.25
19.04
1 125.28
-19.98
42.22
83.53
Profitability ratios
Return on assets %
0.03
-0
-0.06
-0.13
-0.05
0.05
Return on equity %
0.04
-0
-0.08
-0.23
-0.08
0.08
Return on invested capital %
18.3
3.66
-26.46
-59.17
-15.87
21.66
Gross margin %
44.73
44.98
41.19
22.15
29.97
164.75
Operating margin %
9
1.34
-12.38
-32.9
-6.19
31.07
EBITDA margin %
6.3
14.13
0.21
-17.22
4.11
72.01
Net margin %
6.66
-0.41
-13.43
-33.05
-8.14
29.82
Liquidity ratios
Quick ratio
4.55
5.2
2.59
0.92
1.8
7.76
Current ratio
5.5
6.42
4.56
2.78
3.41
15.59
Inventory turnover
3.68
4.09
2.39
1.96
2.49
—
Asset turnover
0.39
0.45
0.42
0.39
0.6
0.61
Solvency ratios
Debt to assets ratio
—
—
—
0.51
—
—
Debt to equity ratio
—
—
—
0.89
—
—
Long term debt to total assets ratio
0.22
0.19
0.2
0.27
0.23
0.81
Long term debt to total equity ratio
0.31
0.26
0.3
0.48
0.38
1.28
Per share metrics
Operating cash flow per share
0.18
0.13
-0.2
-0.6
0.04
0.22
EBIT per share
-0.19
0.03
-0.32
-0.74
-0.2
0.27
EBITDA per share
0.13
0.36
0.01
-0.39
0.13
0.58
Total debt per share
—
—
—
2.88
—
—
Cash per share
1.1
1.34
0.75
0.13
0.03
0.52
Net current asset value per share
1.69
2.14
1.81
1.51
1.84
7.37
Tangible book value per share
3.89
4.27
3.9
3.21
3.36
13.15
Working capital per share
1.38
1.81
1.41
0.97
1.3
5.47
Book value per share
3.92
4.29
3.92
3.23
3.37
13.2
Haberler
ImmuCell yönetim kurulu üyeleri 2026 yıllık toplantısında ayrılacak
ImmuCell directors to step down at 2026 annual meeting, board changes expected
ImmuCell yeni yönetici istihdam anlaşmalarını ve opsiyon hibelerini açıkladı
ImmuCell announces new executive employment agreements and option grants
Niche Focus & Regulation Shape the Future of Healthcare Firms
ImmuCell Corporation (ICCC) Q4 2025 Sales/Trading Call Transcript
ImmuCell’in 2025 4. Çeyrek Kazanç Görüşmesi Hisse Senedinde Olumlu Harekete Neden Oldu
Earnings call transcript: ImmuCell Q4 2025 sees positive stock movement
ImmuCell, 4. çeyrek satışlarını 7,6 milyon dolar olarak açıkladı ve odağını First Defense’e kaydırdı
ImmuCell reports Q4 sales of $7.6 million, shifts focus to First Defense
ImmuCell Puts Re-Tain On Pause After FDA Letter - ImmuCell (NASDAQ:ICCC)
The Zacks Analyst Blog AbbVie, The Coca-Cola, Chevron, ImmuCell and Precipio